Article

Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypes

2021-05-12

Abstract excerpt

<h4>Summary</h4> For muscle-invasive bladder cancer (MIBC), there are no tissue biomarkers in clinical use that identify patients sensitive or resistant to neoadjuvant chemotherapy. The present study investigates how molecular subtypes impact pathological response and survival in 149 patients receiving preoperative cisplatin-based chemotherapy. Tumor classification was performed by transcriptomic profiling and by...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d55d83b1-a7c6-5906-8a89-d4ba4f89b29a
DOI: 10.1101/2021.05.11.21255912

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Different responses to neoadjuvant chemotherapy in urothelial carcinoma molecular subtypesDOI 10.1101/2021.05.11.21255912Read

Immunohistochemistry-based taxonomical classification of bladder cancer predicts response to neoadjuvant chemotherapySemantic proximity Read

Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis.Semantic proximity Read

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.Semantic proximity Read

Identification and Validation of a Novel Prognostic Model Based on Platinum Resistance-Related Genes in Bladder CancerSemantic proximity Read

Update on bladder cancer molecular subtypesSemantic proximity Read

Molecular subtyping of invasive bladder cancer: time to divide and rule?Semantic proximity Read

Molecular Subtypes of Bladder Cancer.Semantic proximity Read

Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.Semantic proximity Read

Risk Classification of Bladder Cancer by Gene Expression and Molecular SubtypeSemantic proximity Read

Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Semantic proximity Read

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapiesSemantic proximity Read

Molecular subtypes of bladder cancer do not display microenvironment- or metastasis-induced plasticitySemantic proximity Read